Evidence map›Paper›PMID 29805535›Full record

ArticleExperimental and therapeutic medicine2018

The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats.

Mervat Y Hanafi, Eman L M Zaher, Soha E M El-Adely, Ahmed Sakr, Ahmed H M Ghobashi, Madiha H Hemly, Amani H Kazem, Maher A Kamel

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Bee venom ameliorates cardiac dysfunction in diabetic hyperlipidemic rats.Experimental biology and medicine (Maywood, N.J.) · 2021
    Article
  15. Antioxidant Activity in Bee Products: A Review.Antioxidants (Basel, Switzerland) · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mervat Y HanafiDepartment of Biochemistry, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Eman L M ZaherDepartment of Biochemistry, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Soha E M El-AdelyDepartment of Biochemistry, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Ahmed SakrDepartment of Pharmacology, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Ahmed H M GhobashiDepartment of Genetics, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Madiha H HemlyDepartment of Biochemistry, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Amani H KazemDepartment of Pathology, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Maher A KamelDepartment of Biochemistry, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Alexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was designed to investigate the therapeutic effects of bee venom (BV) on high-fat diet (HFD)-induced non-alcoholic fatty liver (NAFL) in rats at different levels. Histological manifestations, hepatic lipid content, liver function tests, glucose homeostasis, lipid abnormalities, adipocytokines, lipid peroxidation, disturbed glutathione and antioxidant enzymes systems and dysregulation of Nrf2 transcription factor were assessed. In the present study, the NAFL rats were subcutaneously treated with BV with different doses (0.01, 0.05, 0.1 mg/kg). The results indicated that BV treatment completely normalized the lipid profile values of NAFL rats. Fasting blood sugar, insulin level and homeostatic model assessment of insulin resistance significantly decreased. BV treated rats showed a significantly lower level of all liver enzymes and bilirubin. Moreover, BV treatment significantly increased the levels of active nuclear erythroid factor 2 like 2, glutathione (GSH) (total and reduced), GSH/glutathione disulphide ratio and activities of glutathione reductase, glutathione-S-transferase and glutathione peroxidase (total and Se-dependent). The level of tumor necrosis factor-α was reduced. Treatment showed correction of adiponectin level, and significant downregulation of hepatic triglycerides and cholesterol. At the histological level, BV improved the architecture of liver cells showing normal sinusoids. It may be concluded that BV may represent an interesting therapeutic alternative for the treatment of NAFL disease.

Indexed as

adiponectinbee venomdyslipidemiainsulin resistancenon-alcoholic fatty liverNrf2

Identifiers

PMID29805535
PMCPMC5952098
OpenAlexW2795620449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.